>
Switch to:

Ionis Pharmaceuticals EV-to-EBITDA

: 44.99 (As of Today)
View and export this data going back to 1991. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ionis Pharmaceuticals's enterprise value is $6,990.8 Mil. Ionis Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was $155.4 Mil. Therefore, Ionis Pharmaceuticals's EV-to-EBITDA for today is 44.99.

NAS:IONS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3251.2   Med: -13   Max: 380.1
Current: 44.99
-3251.2
380.1

During the past 13 years, the highest EV-to-EBITDA of Ionis Pharmaceuticals was 380.10. The lowest was -3251.20. And the median was -13.00.

NAS:IONS's EV-to-EBITDA is ranked lower than
65% of the 274 Companies
in the Biotechnology industry.

( Industry Median: 31.58 vs. NAS:IONS: 44.99 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2021-01-28), Ionis Pharmaceuticals's stock price is $59.190000. Ionis Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was $0.48. Therefore, Ionis Pharmaceuticals's PE Ratio for today is 123.31.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Ionis Pharmaceuticals EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Ionis Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -173.99 -595.74 163.88 -326.92 16.96

Ionis Pharmaceuticals Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.78 16.96 22.92 34.64 34.42
Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.

Ionis Pharmaceuticals EV-to-EBITDA Distribution

* The bar in red indicates where Ionis Pharmaceuticals's EV-to-EBITDA falls into.


Ionis Pharmaceuticals EV-to-EBITDA Calculation

Ionis Pharmaceuticals's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=6990.826/155.393
=44.99

Ionis Pharmaceuticals's current Enterprise Value is $6,990.8 Mil.
Ionis Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was 255.702 (Dec. 2019 ) + -46.635 (Mar. 2020 ) + -29.004 (Jun. 2020 ) + -24.67 (Sep. 2020 ) = $155.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Ionis Pharmaceuticals  (NAS:IONS) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Ionis Pharmaceuticals's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=59.190000/0.48
=123.31

Ionis Pharmaceuticals's share price for today is $59.190000.
Ionis Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was 1.28 (Dec. 2019 ) + -0.35 (Mar. 2020 ) + -0.23 (Jun. 2020 ) + -0.22 (Sep. 2020 ) = $0.48.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Ionis Pharmaceuticals EV-to-EBITDA Related Terms

Ionis Pharmaceuticals EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)